Risk Management and Minimisation Workshop

The clear communication of important risks (and more generally, the benefit-risk balance) of a medicinal product is challenging. Risk minimisation activities typically involve education for healthcare professionals and patients/caregivers. This session explores approaches to effectively communicate with these audiences and what to include in an EU-RMP for risk education.